In March 2025, the company introduced new designs for the immediate-to-shopper providing of its Wegovy weight loss drug. The company set up a whole new pharmacy, termed NovoCare, which would cost buyers $499 a month for access to the drug, lower than half the price of the drug as a result of other pharmaceutical distribution networks.[fifty three]N